- Home
- ALM vs ABVX Comparison
ALM vs ABVX Comparison
Compare ALM & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALM | ABVX |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | France |
| Employees | 342 | 69 |
| Industry | Other Metals and Minerals | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALM | ABVX |
|---|---|---|
| Price | $18.64 | $101.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $22.33 | ★ $131.31 |
| AVG Volume (30 Days) | ★ 5.3M | 2.5M |
| Earning Date | 05-20-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $817.94 | $52.14 |
| Revenue Next Year | $158.05 | $4,132.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.16 | $7.41 |
| 52 Week High | $24.41 | $148.83 |
Technical Indicators
Market Signals| Indicator | ALM | ABVX |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 45.78 |
| Support Level | $15.44 | $74.96 |
| Resistance Level | $21.74 | $131.50 |
| Average True Range (ATR) | 1.44 | 7.85 |
| MACD | 0.16 | -0.03 |
| Stochastic Oscillator | 64.68 | 82.61 |
Price Performance
Historical ComparisonAbout ALM Almonty Industries Inc.
Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.